These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7994377)

  • 21. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions.
    Hedeman Joosten PP; Verhagen HJ; Heijnen-Snyder GJ; van Vroonhoven TJ; Sixma JJ; de Groot PG; Eikelboom BC
    J Vasc Surg; 1998 Dec; 28(6):1094-103. PubMed ID: 9845661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions.
    Motterlini R; Foresti R; Vandegriff K; Intaglietta M; Winslow RM
    Am J Physiol; 1995 Aug; 269(2 Pt 2):H648-55. PubMed ID: 7653629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physiological and histopathological response of dogs to exchange transfusion with polyethylene glycol-modified bovine hemoglobin (PEG-Hb).
    Shum KL; León A; Viau AT; Pilon D; Nucci M; Shorr RG
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):655-83. PubMed ID: 8922234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC).
    Cooper CE; Silaghi-Dumitrescu R; Rukengwa M; Alayash AI; Buehler PW
    Biochim Biophys Acta; 2008 Oct; 1784(10):1415-20. PubMed ID: 18457681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings.
    Callas DD; Bacher P; Fareed J
    Semin Thromb Hemost; 1995; 21(2):166-76. PubMed ID: 7660139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
    Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
    Kirchhofer D; Tschopp TB; Baumgartner HR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1098-106. PubMed ID: 7627702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor and its inhibition at the human microvascular anastomosis.
    Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC
    J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preclinical screening test for modified hemoglobin to bridge the gap between animal safety studies and use in human.
    Chang TM; Lister C
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):565-73. PubMed ID: 1391479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of hemoglobin solutions: hemoglobin is a lipopolysaccharide (LPS) binding protein which enhances LPS biological activity.
    Roth RI; Kaca W
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):387-98. PubMed ID: 7994363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filtration-assisted exchange transfusion using alpha alpha Hb, an erythrocyte substitute.
    Hess JR; Wade CE; Winslow RM
    J Appl Physiol (1985); 1991 Apr; 70(4):1639-44. PubMed ID: 1905289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of interleukin-6 production by monocytes for in vitro safety testing of hemoglobin solutions.
    Bleeker WK; de Groot EM; den Boer PJ; Biessels PT; Aarden LA; Bakker JC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):835-40. PubMed ID: 7994407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin enhances tissue factor expression on human malignant cells.
    Siddiqui FA; Amirkhosravi A; Amaya M; Meyer T; Biggerstaff J; Desai H; Francis JL
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):171-7. PubMed ID: 11414630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs.
    Faivre-Fiorina B; Caron A; Fassot C; Fries I; Menu P; Labrude P; Vigneron C
    Am J Physiol; 1999 Feb; 276(2):H766-70. PubMed ID: 9950880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis.
    Orvim U; Barstad RM; Vlasuk GP; Sakariassen KS
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2188-94. PubMed ID: 7489241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
    Alayash AI; D'Agnillo F; Buehler PW
    Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.
    Nicolini FA; Lee P; Malycky JL; Lefkovits J; Kottke-Marchant K; Plow EF; Topol EJ
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):39-48. PubMed ID: 8845461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of purification on transfusional efficacy of hemoglobin solutions.
    Menu P; Labrude P; Grandgeorge M; Vigneron C
    Int J Artif Organs; 1991 Oct; 14(10):672-5. PubMed ID: 1748536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.